000 01460 a2200409 4500
005 20250515092529.0
264 0 _c20080327
008 200803s 0 0 eng d
022 _a0013-7227
024 7 _a10.1210/en.2007-0828
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGarcia, José M
245 0 0 _aGhrelin prevents cisplatin-induced mechanical hyperalgesia and cachexia.
_h[electronic resource]
260 _bEndocrinology
_cFeb 2008
300 _a455-60 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
650 0 4 _aAnimals
650 0 4 _aAntineoplastic Agents
_xtoxicity
650 0 4 _aBehavior, Animal
_xdrug effects
650 0 4 _aBody Weight
_xdrug effects
650 0 4 _aCachexia
_xchemically induced
650 0 4 _aCisplatin
_xtoxicity
650 0 4 _aDrug Interactions
650 0 4 _aEating
_xdrug effects
650 0 4 _aGhrelin
_xblood
650 0 4 _aHyperalgesia
_xchemically induced
650 0 4 _aInsulin-Like Growth Factor I
_xmetabolism
650 0 4 _aMale
650 0 4 _aNeoplasms
_xdrug therapy
650 0 4 _aRats
650 0 4 _aRats, Sprague-Dawley
700 1 _aCata, Juan P
700 1 _aDougherty, Patrick M
700 1 _aSmith, Roy G
773 0 _tEndocrinology
_gvol. 149
_gno. 2
_gp. 455-60
856 4 0 _uhttps://doi.org/10.1210/en.2007-0828
_zAvailable from publisher's website
999 _c17481569
_d17481569